Interview with Dr. John Marshall and Dr. Tony Shields on MI FOLFOXai™
January 8th, 2021
In this interview Dr. Marshall and Dr. Shields discuss the findings of their paper and how we can better predict which metastatic colorectal cancer patients will benefit from first-line FOLFOX+BV followed by FOLFIRI+BV or vice versa.